Immune monitoring of allograft status in kidney transplant recipients
Frontiers in Nephrology · 08.11.2023 · 3
DOI: 10.3389/fneph.2023.1293907 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Nephrology, online erschienen am 08.11.2023. Verfasst von Hwarang S Han und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Dell Medical School, University of Texas at Austin, Austin, TX, United States. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kidney transplant patients require careful management of immunosuppression to avoid rejection while minimizing the risk of infection and malignancy for the best long-term outcome. The gold standard for monitoring allograft status and immunosuppression adequacy is a kidney biopsy, but this is invasive and costly. Conventional methods of allograft monitoring, such as serum creatinine level, are non-specific. Although they alert physicians to the need to evaluate graft dysfunction, by the time there is a clinical abnormality, allograft damage may have already occurred. The development of novel and non-invasive methods of evaluating allograft status are important to improving graft outcomes. This review summarizes the available conventional and novel methods for monitoring allograft status after kidney transplant. Novel and less invasive methods include gene expression, cell-free DNA, urinary biomarkers, and the use of artificial intelligence. The optimal method to manage patients after kidney transplant is still being investigated. The development of less invasive methods to assess allograft function has the potential to improve patient outcomes and allow for a more personalized approach to immunosuppression management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology, Department of Internal Medicine, Dell Medical School, University of Texas at Austin, Austin, TX, United States.
Zitieren
APA
Han, H. S., & Lubetzky, M. L. (2023). Immune monitoring of allograft status in kidney transplant recipients. Frontiers in Nephrology, 3. https://doi.org/10.3389/fneph.2023.1293907
Vancouver
Han HS, Lubetzky ML. Immune monitoring of allograft status in kidney transplant recipients. Frontiers in Nephrology. 2023;3. doi:10.3389/fneph.2023.1293907
BibTeX
@article{Han2023,
author = {Han, Hwarang S and Lubetzky, Michelle L},
title = {Immune monitoring of allograft status in kidney transplant recipients},
journal = {Frontiers in Nephrology},
year = {2023},
volume = {3},
doi = {10.3389/fneph.2023.1293907}
}
EUVIMED